Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jan;36(1):108–114. doi: 10.1128/aac.36.1.108

Structure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus type 1.

T J Bardos 1, R F Schinazi 1, K H Ling 1, A R Heider 1
PMCID: PMC189236  PMID: 1590675

Abstract

Introduction of a reactive 5-mercapto group into some of the cytosine and/or uracil bases of various oligo- and polynucleotides by partial thiolation resulted in several potent inhibitors of the replication of human immunodeficiency virus type 1 (HIV-1) in primary human lymphocytes. These compounds exhibited little if any toxicity against uninfected peripheral blood mononuclear cells and showed 15 to 75 times higher antitemplate activity against a p66/p51 HIV-1 recombinant reverse transcriptase (RT) than against the DNA polymerase alpha from human lymphocytes. In contrast, the unthiolated oligo- and polynucleotides are void of antitemplate activity, and their apparent inhibitory effect on HIV-1 closely paralleled their toxicity for the cells. Partially thiolated poly(dC) (MPdC) was the most potent of all the compounds tested against HIV-1 in peripheral blood mononuclear cells (50% effective concentration, 1.8 micrograms/ml or 0.019 microM), while showing low cytotoxicity (greater than 100 micrograms/ml). The corresponding unmodified poly(dC) showed no anti-HIV-1 activity at 50 micrograms/ml but had pronounced cytotoxicity. MPdC was also a potent inhibitor of HIV-1 RT (50% inhibitory concentration, 0.30 micrograms/ml). The inhibitory activities of thiolated homooligo(dCs) against both HIV-1 replication and HIV-1 RT increased with increasing chain length. The heterooligonucleotides included in this study were designed as structural analogs of portions of the natural primer of HIV-1 RT, i.e., tRNA(3Lys). An 18-mer analog of the 3' terminus, complementary (antisense) to the primer-binding site of the HIV-1 genome, was attached to an oligo(dC) tail and 5-thiolated; this increased its activity and decreased its toxicity. This compound will serve as a new lead in the development of more effective antitemplates against HIV-1.

Full text

PDF
108

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal S., Goodchild J., Civeira M. P., Thornton A. H., Sarin P. S., Zamecnik P. C. Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7079–7083. doi: 10.1073/pnas.85.19.7079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bardos T. J. Antimetabolites: molecular design and mode of action. Top Curr Chem. 1974;52:63–98. doi: 10.1007/3-540-06873-2_14. [DOI] [PubMed] [Google Scholar]
  3. Bardos T. J., Aradi J., Ho Y. K., Kalman T. I. Biochemical properties of 5-sulfur-substituted pyrimidine nucleosides and nucleotides. Ann N Y Acad Sci. 1975 Aug 8;255:522–531. doi: 10.1111/j.1749-6632.1975.tb29255.x. [DOI] [PubMed] [Google Scholar]
  4. Bordier B., Tarrago-Litvak L., Sallafranque-Andreola M. L., Robert D., Tharaud D., Fournier M., Barr P. J., Litvak S., Sarih-Cottin L. Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys). Nucleic Acids Res. 1990 Feb 11;18(3):429–436. doi: 10.1093/nar/18.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cavanaugh P. F., Jr, Ho Y. K., Hughes R. G., Jr, Bardos T. J. Selectivity of antitemplates as inhibitors of deoxyribonucleic acid polymerases. Biochem Pharmacol. 1982 Dec 15;31(24):4055–4060. doi: 10.1016/0006-2952(82)90655-4. [DOI] [PubMed] [Google Scholar]
  6. Chandra P., Bardos T. J. Inhibition of DNA polymerases from RNA tumor viruses by novel template analogues: partially thiolated polycytidylic acid. Res Commun Chem Pathol Pharmacol. 1972 Nov;4(3):615–622. [PubMed] [Google Scholar]
  7. Chandra P., Ebener U., Bardos T. J., Chakrabarti P., Ho Y. K., Mikulski A. J., Zsindely A. Polynucleotides containing 5-mercapto-substituted pyrimidines: inhibition of viral DNA polymerases and the biological implication. Ann N Y Acad Sci. 1975 Aug 8;255:532–543. doi: 10.1111/j.1749-6632.1975.tb29256.x. [DOI] [PubMed] [Google Scholar]
  8. Chandra P., Vogel A., Gerber T. Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS. Cancer Res. 1985 Sep;45(9 Suppl):4677s–4684s. [PubMed] [Google Scholar]
  9. Chou T. C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55. doi: 10.1016/0065-2571(84)90007-4. [DOI] [PubMed] [Google Scholar]
  10. Chu C. K., Schinazi R. F., Ahn M. K., Ullas G. V., Gu Z. P. Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells. J Med Chem. 1989 Mar;32(3):612–617. doi: 10.1021/jm00123a018. [DOI] [PubMed] [Google Scholar]
  11. Chu C. K., Schinazi R. F., Arnold B. H., Cannon D. L., Doboszewski B., Bhadti V. B., Gu Z. P. Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Biochem Pharmacol. 1988 Oct 1;37(19):3543–3548. doi: 10.1016/0006-2952(88)90383-8. [DOI] [PubMed] [Google Scholar]
  12. Eriksson B. F., Schinazi R. F. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro. Antimicrob Agents Chemother. 1989 May;33(5):663–669. doi: 10.1128/aac.33.5.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goodchild J., Agrawal S., Civeira M. P., Sarin P. S., Sun D., Zamecnik P. C. Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5507–5511. doi: 10.1073/pnas.85.15.5507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HOARD D. E., OTT D. G. CONVERSION OF MONO- AND OLIGODEOXYRIBONUCLEOTIDES TO 5-TRIPHOSPHATES. J Am Chem Soc. 1965 Apr 20;87:1785–1788. doi: 10.1021/ja01086a031. [DOI] [PubMed] [Google Scholar]
  15. Ho Y. K., Aradi J., Bardos T. J. Enzymatic synthesis of polyuridylic acid containing modified bases. Nucleic Acids Res. 1980 Jul 25;8(14):3175–3191. doi: 10.1093/nar/8.14.3175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ho Y. K., Fiel R. J., Aradi J., Bardos T. J. Structural characterization of partially thiolated poly(cytidylic acid). Biochemistry. 1979 Dec 11;18(25):5630–5635. doi: 10.1021/bi00592a017. [DOI] [PubMed] [Google Scholar]
  17. Ho Y. K., Kung M. P., Bardos T. J. Oligonucleotides containing modified bases. I. Inhibition of DNA and RNA polymerases by partially thiolated oligocytidylic acids. Biochem Biophys Res Commun. 1976 Dec 20;73(4):903–910. doi: 10.1016/0006-291x(76)90207-2. [DOI] [PubMed] [Google Scholar]
  18. Ho Y. K., Preisler H. D., Bardos T. J. Effects of partially thiolated polycytidylic acid on the clonogenicity of murine leukemic stem cells. Cancer Res. 1979 Aug;39(8):3163–3166. [PubMed] [Google Scholar]
  19. Ho Y. K., Reddy A. R., Aradi J., Minowada J., Bardos T. J. Inhibition of DNA polymerase alpha from leukemic and normal human cells by partially thiolated human deoxyribonucleic acids. Cancer Biochem Biophys. 1985 Dec;8(2):85–94. [PubMed] [Google Scholar]
  20. Hobbs J., Sternbach H., Sprinzl M., Eckstein F. Polynucleotides containing 2'-chloro-2'-deoxyribose. Biochemistry. 1972 Nov 7;11(23):4336–4344. doi: 10.1021/bi00773a021. [DOI] [PubMed] [Google Scholar]
  21. Kalman T. I., Bardos T. J. The autoxidation of 5-mercaptouracil and 5-mercaptodeoxyuridine. J Am Chem Soc. 1967 Mar 1;89(5):1171–1175. doi: 10.1021/ja00981a024. [DOI] [PubMed] [Google Scholar]
  22. Kung M. P., Ho Y. K., Bardos T. J. 5-Mercaptopolyuridylic acid (MPU), a potent inhibitor of the reverse transcriptase from avian myeloblastosis virus. Res Commun Chem Pathol Pharmacol. 1982 May;36(2):215–228. [PubMed] [Google Scholar]
  23. Kung M. P., Ho Y. K., Bardos T. J. Action of partially thiolated polynucleotides on the DNA polymerase alpha from regenerating rat liver. Cancer Res. 1976 Dec;36(12):4537–4542. [PubMed] [Google Scholar]
  24. Kung M. P., Ho Y. K., Lalka D., Bardos T. J. Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents. Cancer Res. 1984 Oct;44(10):4602–4606. [PubMed] [Google Scholar]
  25. Li Z. R., Ho Y. K., Bardos T. J. Inhibition of DNA polymerase-alpha from rat hepatoma with a series of new synthetic polynucleotides. Cancer Biochem Biophys. 1983;6(4):221–228. [PubMed] [Google Scholar]
  26. Mikulski A. J., Bardos T. J., Chakrabarti P., Kalman T. I., Zsindely A. Inhibition of DNA-dependent RNA polymerase with partially thiolated polynucleotides. Biochim Biophys Acta. 1973 Sep 7;319(3):294–303. doi: 10.1016/0005-2787(73)90169-x. [DOI] [PubMed] [Google Scholar]
  27. Paffenholz V., Hung-Van-Le, Ho Y., Bardos T. J. Uptake of partially thiolated DNA by ascites tumor cells. Cancer Res. 1976 Apr;36(4):1445–1452. [PubMed] [Google Scholar]
  28. Schinazi R. F., Cannon D. L., Arnold B. H., Martino-Saltzman D. Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1988 Dec;32(12):1784–1787. doi: 10.1128/aac.32.12.1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schinazi R. F., Eriksson B. F., Hughes S. H. Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptases. Antimicrob Agents Chemother. 1989 Jan;33(1):115–117. doi: 10.1128/aac.33.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schinazi R. F., Sommadossi J. P., Saalmann V., Cannon D. L., Xie M. Y., Hart G. C., Smith G. A., Hahn E. F. Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1990 Jun;34(6):1061–1067. doi: 10.1128/aac.34.6.1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Szabo L., Kalman T. I., Bardos T. J. The reaction of 5-bromouracil derivatives with sulfur nucleophiles, and a novel synthetic route to 5-sulfur-substituted uracils and nucleotides. J Org Chem. 1970 May;35(5):1434–1437. doi: 10.1021/jo00830a038. [DOI] [PubMed] [Google Scholar]
  32. Tuominen F. W., Kenney F. T. Inhibition of the DNA polymerase of Rauscher leukemia virus by single-stranded polyribonucleotides. Proc Natl Acad Sci U S A. 1971 Sep;68(9):2198–2202. doi: 10.1073/pnas.68.9.2198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yoshikawa M., Kato T., Takenishi T. A novel method for phosphorylation of nucleosides to 5'-nucleotides. Tetrahedron Lett. 1967 Dec;50:5065–5068. doi: 10.1016/s0040-4039(01)89915-9. [DOI] [PubMed] [Google Scholar]
  34. Zamecnik P. C., Goodchild J., Taguchi Y., Sarin P. S. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4143–4146. doi: 10.1073/pnas.83.12.4143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zamecnik P. C., Stephenson M. L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A. 1978 Jan;75(1):280–284. doi: 10.1073/pnas.75.1.280. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES